Abstract
Purpose Phantoms are a basic tool for assessing and verifying performance in CT research and clinical practice. Patient-based realistic lung phantoms accurately representing textures and densities are essential in developing and evaluating novel CT hardware and software. This study introduces PixelPrint, a 3D printing solution to create patient-based lung phantoms with accurate attenuation profiles and textures.
Methods PixelPrint, a software tool, was developed to convert Patient DICOM images directly into printer instructions (G-code). The density was modeled as the ratio of filament to voxel volume to emulate attenuation profiles for each voxel. A calibration phantom was designed to determine the mapping between filament line width and Hounsfield Units (HU) within the range of human lungs. For evaluation of PixelPrint, a phantom based on a human lung slice was manufactured and scanned with the same CT scanner and protocol used for the patient scan. Density and geometrical accuracy between phantom and patient CT data was evaluated for various anatomical features in the lung.
Results For the calibration phantom, measured mean Hounsfield units show a very high level of linear correlation with respect to the utilized filament line widths, (r > 0.999). Qualitatively, the CT image of the patient-based phantom closely resembles the original CT image both in texture and contrast levels, with clearly visible vascular and parenchymal structures. Regions-of-interest (ROIs) comparing attenuation illustrated differences below 15 HU. Manual size measurements performed by an experienced thoracic radiologist reveal a high degree of geometrical correlation of details between identical patient and phantom features, with differences smaller than the intrinsic spatial resolution of the scans.
Conclusion The present study demonstrates the feasibility of 3D printed patient-based lung phantoms with accurate organ geometry, image texture, and attenuation profiles. PixelPrint will enable applications in the research and development of CT technology, including further development in radiomics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge support through the National Institutes of Health (R01CA249538).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board (IRB) at the University of Pennsylvania approved this retrospective study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Finally, we would like to allow the larger medical, academic, and industrial CT community to have access to PixelPrint. We can make copies of our phantoms available as well as customized phantoms based on specific CT images, which could include various lung diseases. For additional information, please see the project homepage: www.pennmedicine.org/CTResearch/PixelPrint.